March 3, 2026Open Access

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

Key Points

Poor prognosis is linked to high levels of UBE2D1 expression in head and neck squamous cell carcinoma.
UBE2D1 is frequently overexpressed, correlating with adverse clinical outcomes in the disease.
Results imply that UBE2D1 may serve as a prognostic biomarker for patient management in HNSCC.
Further validation is needed to confirm UBE2D1's role in predicting immunotherapy response.

Abstract

UBE2D1 is frequently overexpressed in HNSCC and is associated with adverse clinical outcomes. Although its association with immunotherapy response requires further validation, UBE2D1 may be a prognostic biomarker in HNSCC.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Prathibha Prasad

Paramasivam Arumugam

Journals

Journal of Oral Biology and Craniofacial Research

Actions

Institutions

Saveetha University

Ajman University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study